Editorial: Intelligent analysis of biomedical imaging data for precision medicine

Kuanquan Wang, Shuo Li, Xiuying Wang, Jun Feng, Yong XuFrontiers in Medicine 2022 · DOI · OpenAlex

Abstract

Biomedical imaging serves as a cornerstone of modern clinical practice, yet its utility is often limited by subjective interpretation and technical artifacts. This article synthesizes a collection of research focused on leveraging intelligent analysis—primarily deep learning and radiomics—to transform imaging into a quantitative tool for precision medicine. By automating tasks such as lesion segmentation, histological risk assessment, and survival prediction, these advancements aim to provide objective, reproducible insights across oncology, orthopedics, and pulmonology.

Introduction

The transition toward precision medicine requires a move from qualitative "eyeballing" of medical scans to quantitative, objective evaluations. While modalities like CT, MRI, and PET are indispensable, they face two primary hurdles: the "human factor," where diagnostic accuracy varies based on a radiologist's experience, and the "image quality factor," where artifacts and low contrast can obscure critical details. Intelligent analysis acts as the bridge, enabling automated pre-operative planning, therapy response prediction, and survival estimation.

Methodological Innovations in Intelligent Analysis

Recent research has introduced several novel methodological approaches to overcome traditional imaging limitations:

  • Hybrid Architectures: By combining deep learning models (e.g., U-Net, DeepLab V3+) with "hand-crafted" radiomics features, researchers have improved the differentiation of complex pathologies, such as brain abscesses versus cystic gliomas.
  • Advanced Optimization: To address irregular tumor shapes in low-contrast images, researchers applied "wormhole theory" to quantum-behaved particle swarm optimization (QPSO), enhancing segmentation accuracy.
  • Uncertainty Modeling: The Cost-Sensitive Uncertainty Hypergraph Learning (CSUHL) scheme was developed to identify lymph nodes in lung cancer scans. This approach explicitly models epistemic and aleatoric uncertainty, leading to higher-quality data representations.
  • Domain Adaptation: To ensure models remain effective across different hospitals and scanners, semi-supervised frameworks and unsupervised domain adaptation have been proposed to leverage unannotated data.
  • Attention Mechanisms: The integration of "Squeeze and Excitation" (SE) modules and channel attention helps networks focus on essential features while filtering noise in complex 3D volumes, such as liver or knee scans.

Clinical Applications and Insights

The scope of intelligent analysis extends beyond simple segmentation to complex diagnostic and prognostic tasks:

Oncology and Pathology

In lung cancer diagnosis, Siamese pyramid fusion networks that combine metabolic data (PET) with anatomical data (CT) have significantly outperformed single-modality models. Furthermore, for melanoma recognition in large-scale Whole-Slide Images (WSIs), multi-scale feature fusion has proven effective in handling irregularly shaped lesions. Beyond identification, models are now predicting histological risk; for example, the "acute angle between adjacent lobulations" has been identified as a quantitative indicator for thymoma risk.

Orthopedics and Pulmonology

In orthopedic imaging, incorporating "prior shape constraints" into adversarial loss functions has improved the segmentation of healthy versus pathological bone in the knee. In pulmonology, ensemble models have been deployed to analyze COVID-19 lung lesions, achieving results that occasionally outperform manual human segmentation.

Key Quantitative Results

The efficacy of these intelligent systems is supported by strong performance metrics across various benchmarks:

  • Lymph Node Detection: The CSUHL model achieved a prediction accuracy of 0.95238, surpassing previous state-of-the-art methods.
  • COVID-19 Analysis: An ensemble of DeepLab V3+, U-Net, PAN, and FPN reached an Intersection over Union (IoU) of 0.7279.
  • Knee Segmentation: The 3D nnU-Net architecture achieved a validation score exceeding 76 on the public SKI10 dataset.
  • Survival Prediction: A streamlined model using only 11 selected radiomics features successfully predicted progression-free survival (PFS) in lung cancer patients.

Conclusion and Future Directions

While the technical achievements are significant, several challenges remain. Generalization across different clinical domains (varying scanners and protocols) is a primary hurdle. Additionally, the segmentation of thin or ambiguous structures in low-contrast environments remains difficult. The ultimate goal is the seamless integration of these intelligent tools into personalized clinical workflows, requiring extensive real-world validation to ensure they truly enhance patient outcomes in a precision medicine framework.

Summary updated

Abstract

EDITORIAL article Front. Med., 26 September 2022Sec. Precision Medicine Volume 9 - 2022 | https://doi.org/10.3389/fmed.2022.1017751
BibTeX
@inproceedings{wang2022editorial,
  author = {Kuanquan Wang and Shuo Li and Xiuying Wang and Jun Feng and Yong Xu},
  title = {{Editorial: Intelligent analysis of biomedical imaging data for precision medicine}},
  booktitle = {Frontiers in Medicine},
  year = {2022},
  doi = {10.3389/fmed.2022.1017751},
}
Figure